Barrington Research Reaffirms “Outperform” Rating for Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC)‘s stock had its “outperform” rating restated by investment analysts at Barrington Research in a note issued to investors on Wednesday,Benzinga reports. They presently have a $78.00 price objective on the stock. Barrington Research’s target price would suggest a potential upside of 22.66% from the company’s previous close.

A number of other analysts have also weighed in on the stock. JPMorgan Chase & Co. decreased their target price on shares of Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a report on Thursday, August 7th. Evercore ISI raised shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 target price on the stock in a report on Tuesday, August 26th. Baird R W cut shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Finally, Leerink Partners set a $75.00 price target on shares of Henry Schein in a research note on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $76.67.

Henry Schein Stock Performance

Henry Schein stock opened at $63.59 on Wednesday. The firm’s 50 day simple moving average is $66.81 and its 200 day simple moving average is $68.52. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $7.71 billion, a PE ratio of 20.51, a price-to-earnings-growth ratio of 2.10 and a beta of 0.81. Henry Schein has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business’s revenue was up 3.3% on a year-over-year basis. During the same period last year, the company posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, analysts expect that Henry Schein will post 4.74 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors have recently made changes to their positions in the business. Vanguard Personalized Indexing Management LLC boosted its stake in shares of Henry Schein by 3.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock valued at $341,000 after purchasing an additional 157 shares in the last quarter. Equitable Trust Co. raised its holdings in Henry Schein by 3.1% during the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock valued at $388,000 after buying an additional 158 shares during the last quarter. CW Advisors LLC raised its holdings in Henry Schein by 2.8% during the 2nd quarter. CW Advisors LLC now owns 5,913 shares of the company’s stock valued at $432,000 after buying an additional 163 shares during the last quarter. TD Asset Management Inc raised its holdings in Henry Schein by 0.8% during the 2nd quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock valued at $1,608,000 after buying an additional 164 shares during the last quarter. Finally, Radnor Capital Management LLC raised its holdings in Henry Schein by 1.6% in the 2nd quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after purchasing an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.